Fp Chem Structure (Fluticasone Propionate Salmeterol Inhalation Powde 1)
Fluticasone Propionate And Salmeterol Powder, Metered
Product Images NDC 63629-8809
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate And Salmeterol (NDC 63629-8809). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 8 (Fluticasone Propionate Salmeterol Inhalation Powde 10)
Teva Logo (Fluticasone Propionate Salmeterol Inhalation Powde 11)
Teva Logo (Fluticasone Propionate Salmeterol Inhalation Powde 12)
Figurr A (Fluticasone Propionate Salmeterol Inhalation Powde 13)
This text seems to be a list of features regarding a medical device. It mentions a "dose counter", a "Vent", a "Mouthpiece", and a "Yellow cap". It is likely describing a medication inhaler.*
Figure B (Fluticasone Propionate Salmeterol Inhalation Powde 14)
This is a description of an inhaler that has 60 doses when it is full and zero doses when it is empty.*
Figure C (Fluticasone Propionate Salmeterol Inhalation Powde 15)
Figure C (Fluticasone Propionate Salmeterol Inhalation Powde 16)
Breathe Out Image (Fluticasone Propionate Salmeterol Inhalation Powde 17)
Figure F (Fluticasone Propionate Salmeterol Inhalation Powde 18)
Figure G (Fluticasone Propionate Salmeterol Inhalation Powde 19)
Salmeterol Chem Structure (Fluticasone Propionate Salmeterol Inhalation Powde 2)
Figure H (Fluticasone Propionate Salmeterol Inhalation Powde 20)
Teva Logo (Fluticasone Propionate Salmeterol Inhalation Powde 21)
Figure 1 (Fluticasone Propionate Salmeterol Inhalation Powde 3)
Figure 2 (Fluticasone Propionate Salmeterol Inhalation Powde 4)
Figure 3 (Fluticasone Propionate Salmeterol Inhalation Powde 5)
Figure 4 (Fluticasone Propionate Salmeterol Inhalation Powde 6)
Figure 5 (Fluticasone Propionate Salmeterol Inhalation Powde 7)
Figure 6 (Fluticasone Propionate Salmeterol Inhalation Powde 8)
Figure 7 (Fluticasone Propionate Salmeterol Inhalation Powde 9)
This is a chart showing the mean change in FEV (forced expiratory volume) in liters for different treatments. The treatments have different names such as FSMDPI and $P MDPI, followed by doses such as 232 meg or 113 meg, and number of participants labeled as N=XX. There is a row for placebo as well. The chart shows the results of the treatment over time (labeled as Day 1 and Hour) with the corresponding mean changes in FEV in liters on the Y-axis. The baseline is also included for reference.*
Label (Lbl636298809)
Fluticasone Propionate and Salmeterol Inhalation Powder is a prescription medication used for oral inhalation only. Each metered dose contains 113 mcg of fluticasone proprionate and 14 mcg of salmeterol base, equivalent to 20.3 mcg of salmeterol xinafoate, with lactose. It is important never to wash or put any part of the inhaler in water, and to store it at controlled room temperature between 15°C and 25°C (59°F and 77°F), avoiding exposure to extreme heat, cold, or humidity. The product has 60 metered inhalations, is only available by prescription, and has an NDC number of 63629-8809-1.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
